glp-1 rheumatoid arthritis study Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? Study published Feb 2026! ,

Indianapolis, IN: Eli Lilly and Co

Reinforce Insulin Sensitivity Patients with insulin resistance are more likely to stall Enhance insulin signaling and AMPK activation Improve glucose uptake Support postprandial control Support with SLM+ which has been shown to: The ingredients work in synergy in SLM+ , making it a strong non-pharmaceutical support layer

Acanthosis Nigricans Directly addresses the underlying insulin resistance, helping to fade the dark, velvety patches often found in skin folds

Kristian Brock, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, B15 2TT, UK

Metformin is not a GLP-1 drug it is in a class of medications called biguanides